Advances in non-viral DNA vectors for gene therapy

CL Hardee, LM Arévalo-Soliz, BD Hornstein… - Genes, 2017 - mdpi.com
Uses of viral vectors have thus far eclipsed uses of non-viral vectors for gene therapy
delivery in the clinic. Viral vectors, however, have certain issues involving genome …

Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity

JJ Suschak, JA Williams… - Human vaccines & …, 2017 - Taylor & Francis
ABSTRACT A major advantage of DNA vaccination is the ability to induce both humoral and
cellular immune responses. DNA vaccines are currently used in veterinary medicine, but …

Contemporary Transposon Tools: A Review and Guide through Mechanisms and Applications of Sleeping Beauty, piggyBac and Tol2 for Genome Engineering

N Sandoval-Villegas, W Nurieva, M Amberger… - International journal of …, 2021 - mdpi.com
Transposons are mobile genetic elements evolved to execute highly efficient integration of
their genes into the genomes of their host cells. These natural DNA transfer vehicles have …

Gene therapy with the sleeping beauty transposon system

P Kebriaei, Z Izsvák, SA Narayanavari, H Singh… - Trends in Genetics, 2017 - cell.com
The widespread clinical implementation of gene therapy requires the ability to stably
integrate genetic information through gene transfer vectors in a safe, effective, and …

Electrochemotherapy of tumors as in situ vaccination boosted by immunogene electrotransfer

G Sersa, J Teissie, M Cemazar, E Signori… - Cancer Immunology …, 2015 - Springer
Electroporation is a platform technology for drug and gene delivery. When applied to cell in
vitro or tissues in vivo, it leads to an increase in membrane permeability for molecules which …

Vector design for improved DNA vaccine efficacy, safety and production

JA Williams - Vaccines, 2013 - mdpi.com
DNA vaccination is a disruptive technology that offers the promise of a new rapidly deployed
vaccination platform to treat human and animal disease with gene-based materials …

Recombinase-mediated cassette exchange (RMCE)—a rapidly-expanding toolbox for targeted genomic modifications

S Turan, C Zehe, J Kuehle, J Qiao, J Bode - Gene, 2013 - Elsevier
Starting in 1991, the advance of Tyr-recombinases Flp and Cre enabled superior strategies
for the predictable insertion of transgenes into compatible target sites of mammalian cells …

Recombinase-mediated cassette exchange (RMCE): traditional concepts and current challenges

S Turan, M Galla, E Ernst, J Qiao, C Voelkel… - Journal of molecular …, 2011 - Elsevier
Traditional DNA transduction routes used for the modification of cellular genomes are
subject to unpredictable alterations, as the cell-intrinsic repair machinery may affect both the …

Vectors and strategies for nonviral cancer gene therapy

J Pahle, W Walther - Expert Opinion on Biological Therapy, 2016 - Taylor & Francis
Introduction: This review presents recent developments in the use of nonviral vectors and
transfer technologies in cancer gene therapy. Tremendous progress has been made in …

Going non-viral: the Sleeping Beauty transposon system breaks on through to the clinical side

M Hudecek, Z Izsvák, S Johnen, M Renner… - Critical reviews in …, 2017 - Taylor & Francis
Molecular medicine has entered a high-tech age that provides curative treatments of
complex genetic diseases through genetically engineered cellular medicinal products. Their …